Study outcome won't sway company on eye drug
Wednesday, August 27, 2008 - 13:35
in Health & Medicine
WASHINGTON (AP) -- What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?...
Read the whole article
See latest science articles from AP Health
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Related
- Free drug samples may end up costing uninsured moreFri, 5 Sep 2008, 6:22:24 EDT
- Treatment outcomes highlight dangers of extensively drug-resistant tuberculosisWed, 6 Aug 2008, 17:28:59 EDT
- Brand-name drugs do not appear superior to generic drugs for treating cardiovascular diseasesTue, 2 Dec 2008, 17:23:13 EST
- HIV drug maraviroc effective for drug-resistant patientsWed, 1 Oct 2008, 18:07:48 EDT
- What is the best strategy for treating Helicobacter pylori?Tue, 23 Sep 2008, 11:38:09 EDT